Sevoflurane

From WikiCover

Sevoflurane (trade name Sojourn) is the leading anesthetic gas used today in modern anesthesiology due to ease of administration and rapid clearance from the body after administration. Sevoflurane is the best selling anesthetic gas worldwide, with a US market size of approximately $400 million. Manufacturers include Abbott Labs, Baxter, and now Minrad.

On July 23, 2007, Southridge Technology Group announced that its subsidiary, RxElite Holdings, reports its successful launch of the modern generic anesthetic, Sevoflurane. RxElite is the exclusive commercial partner of Sojourn in the United States for Minrad International, who announced in May that the U.S. Food and Drug Administration had given its approval to market Sojourn, its generic version of Sevoflurane.

According to IMS data, the U.S. Sevoflurane market has grown 11% per year for the last three years (in number of units), and RxElite believes the anticipated continued market growth (in units) will provide a strong growth opportunity for the company in this specialty market. RxElite is the third entrant into the US Sevoflurane market behind Abbott Labs and Baxter.